LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human Clinical Trial
BostonGene to Support Phase 1/2 Clinical Trial of TROP2-Directed Antibody-Drug Conjugate (ADC) in Patients with…
BostonGene to Support Phase 1/2 Clinical Trial of TROP2-Directed Antibody-Drug Conjugate (ADC) in Patients with…
40% of assets remain unmonitored and pose the biggest threat to organizations globally SAN FRANCISCO--(BUSINESS…
35-subject SWING Trial evaluates the safety, performance of Surmodics’ Sundanceâ„¢ Sirolimus Drug-Coated Balloon Updated safety…
Revenues Grew 6% to $63.9 million;GAAP Operating Income of $12.7 million and Adjusted EBITDA of…
Revenues Grew 6% to $63.9 million;GAAP Operating Income of $12.7 million and Adjusted EBITDA of…
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider…
Business leaders believe up to 40% reduction in business costs is possible if generative AI…
Inaugural Revenue and Profit Recorded on Commencement of Lithium Concentrate Shipments Revenue of $47.1 million…
TORONTO--(BUSINESS WIRE)--$GENM #copper--Generation Mining Limited (TSX:GENM)(OTCQB: GENMF)(“Gen Mining†or the “Companyâ€) is pleased to announce…
Oral arguments in appeal of ‘793 PTAB decision set for December 4, 2023 PDUFA goal…